These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7796971)

  • 21. Effect of vaccination on shedding of Aujeszky's disease virus in experimentally infected pigs and role of vaccination in herd health programmes.
    Smíd B; Rodák L; Valícek L; Sabo A; Matis J
    Acta Vet Hung; 1994; 42(2-3):391-6. PubMed ID: 7810436
    [No Abstract]   [Full Text] [Related]  

  • 22. Test and removal procedures vs vaccination for control and eradication of pseudorabies in Missouri.
    Thawley DG; Wright JC; Solorzano RF; Downard JA; Schnurrenberger LW
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):448-63. PubMed ID: 233388
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombination in vivo of pseudorabies vaccine strains to produce new virus strains.
    Katz JB; Henderson LM; Erickson GA
    Vaccine; 1990 Jun; 8(3):286-8. PubMed ID: 2163577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins.
    Dory D; Torché AM; Béven V; Blanchard P; Loizel C; Cariolet R; Jestin A
    Vaccine; 2005 May; 23(26):3483-91. PubMed ID: 15837372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies.
    Adam M; Lepottier MF; Eloit M
    Vet Microbiol; 1994 Nov; 42(2-3):205-15. PubMed ID: 7886933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of vaccination against Aujeszky's disease on the physical development and fertility of boars].
    Weitze KF; Gaus J
    Dtsch Tierarztl Wochenschr; 1983 Oct; 90(10):434-7. PubMed ID: 6317331
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of Aujeszky's disease.
    Kit S; Sheppard M; Kit M
    Vet Rec; 1986 Mar; 118(11):310. PubMed ID: 3010537
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular analysis of pseudorabies viral vaccines and their rapid differentiation from wild-type isolates using DNA-amplified glycoprotein I and thymidine kinase gene segment polymorphisms.
    Katz JB; Pedersen JC
    Biologicals; 1992 Sep; 20(3):187-95. PubMed ID: 1333775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccine engineering. Violation of rules alleged.
    Palca J
    Nature; 1986 May 15-21; 321(6067):190. PubMed ID: 3012349
    [No Abstract]   [Full Text] [Related]  

  • 30. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E.
    Firkins LD; Weigel RM; Biehl LG; Hahn EC
    Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1).
    Dory D; Fischer T; Béven V; Cariolet R; Rziha HJ; Jestin A
    Vaccine; 2006 Sep; 24(37-39):6256-63. PubMed ID: 16814432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs.
    Yuan Z; Zhang S; Liu Y; Zhang F; Fooks AR; Li Q; Hu R
    Vaccine; 2008 Mar; 26(10):1314-21. PubMed ID: 18262313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of hyperimmune serum, vaccination, and certain management procedures for control of pseudorabies in swine.
    Hsu FS; Lee RC
    J Am Vet Med Assoc; 1984 Jun; 184(12):1463-6. PubMed ID: 6330015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal application of Aujeszky's disease virus strain Begonia with tocopherol-based adjuvant and a novel design injection device.
    Visser N; Egger W; Lütticken D
    Acta Vet Hung; 1994; 42(2-3):413-8. PubMed ID: 7810440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of Aujeszky disease control using marker vaccines].
    Stegeman JA
    Tijdschr Diergeneeskd; 1995 Sep; 120(17):502-4. PubMed ID: 7570555
    [No Abstract]   [Full Text] [Related]  

  • 37. Challenges of the final stages of the ADV eradication program.
    Pensaert M; Morrison RB
    Vet Res; 2000; 31(1):141-5. PubMed ID: 10726642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Construction and immunogenicity of recombinant pseudorabies virus expressing the modified GP5m protein of porcine reproduction and respiratory syndrome virus].
    Jiang YB; Fang LR; Xiao SB; Zhang H; Chen HC
    Sheng Wu Gong Cheng Xue Bao; 2005 Nov; 21(6):858-64. PubMed ID: 16468337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of newborn piglets inoculated with Pseudorabies attenuated vaccine.
    Ling-Hua Z; Xing-Shan T; Yong G; Feng-Zhen Z; Min-Jie M
    Res Vet Sci; 2006 Jun; 80(3):281-6. PubMed ID: 16165173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of intranasal vaccination with plasmid encoding pseudorabies virus glycoprotein B in mice.
    Takada A; Okazaki K; Kida H
    Jpn J Vet Res; 1999 Aug; 47(1-2):25-33. PubMed ID: 10810559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.